“…Liquid Chromatography: 2016 method for simultaneous analysis of GHB, ketamine, norketamine, phenobarbital, thiopental, zolpidem, zopiclone and phenytoin (an anticonvulsant and antiepileptic drug) with LC-MS/MS [ 1559 ]; Enantiomeric separation of citalopram was developed using a reversed phase HPLC with sulfobutylether-beta-cyclodextrin as a chiral mobile phase additive [ 1560 ]; multivariate curve resolution-alternating least squares analysis of HRLC-MS data [ 1561 ]; beta-cyclodextrin-based open-tubular capillary electrochromatography column and application for Enantioseparation of zopiclone, chlorphenamine maleate, brompheniramine maleate, dioxopromethazine hydrochloride, carvedilol, homatropine hydrobromide, homatropine methylbromide, venlafaxine, sibutramine hydrochloride and terbutaline sulfate [ 1562 ]; analysis of psychotropic drugs using an ultra-high-speed HPLC [ 1563 ]; 2017 Response surface methodology based on central composite design accompanied by multivariate curve resolution to model gradient hydrophilic interaction liquid chromatography for separation of five major opium alkaloids [ 1564 ]; 2018 LC/MS/MS for detection of prohibited substances in exhaled breath [ 1565 ]; HPLC-DAD method to characterize thirteen common colorants from five key classes of dyes found in illicit ecstasy and diazepam tablets [ 1566 ]; 2019 reversed-phase liquid chromatography by using functionalized multi-walled carbon nanotubes for separation and analysis of barbiturates, steroid hormones and alkaloids [ 1567 ].…”